Dianthus Therapeutics (DNTH) Change in Account Payables (2017 - 2025)

Dianthus Therapeutics' Change in Account Payables history runs 9 years deep, the most recent figure standing at $3.0 million for Q3 2025.

• In Q3 2025, Change in Account Payables fell 46.84% year-over-year to $3.0 million; the TTM figure through Sep 2025 stood at $6.9 million (down 8.53% YoY), while the FY2024 annual figure was $8.2 million, up 1139.18% from the prior year.
• Change in Account Payables was $3.0 million for Q3 2025 at Dianthus Therapeutics, down from $3.1 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $5.7 million in Q3 2024 to a low of -$4.7 million in Q1 2023.
• Historically, Change in Account Payables has averaged $627578.9 across 5 years, with a median of $773000.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Change in Account Payables tumbled 583.14% in 2022, then jumped 631.05% in 2024.
• A 5-year view of Change in Account Payables shows it stood at $1.2 million in 2021, then tumbled by 129.38% to -$339000.0 in 2022, then surged by 572.86% to $1.6 million in 2023, then jumped by 42.23% to $2.3 million in 2024, then jumped by 31.75% to $3.0 million in 2025.
• The last three Change in Account Payables figures came in at $3.0 million (Q3 2025), $3.1 million (Q2 2025), and -$1.5 million (Q1 2025), per Business Quant data.